AZN icon

AstraZeneca

93.24 USD
+1.72
1.88%
At close Updated Nov 25, 4:00 PM EST
Pre-market
After hours
93.30
+0.06
0.06%
1 day
1.88%
5 days
4.11%
1 month
10.92%
3 months
17.05%
6 months
31.4%
Year to date
41.53%
1 year
40.42%
5 years
77.26%
10 years
173.35%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,471 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™